1.Management of proximal tibial stress fracture associated with advanced knee osteoarthritis: A systematic review
Kumar Mukesh SAINI ; Mahendra SINGH ; Devendra SINGH ; Manohar Prem SEERVI ; Jayavardhan Pera REDDY ; Ramana Neelam REDDY
Chinese Journal of Traumatology 2024;27(3):147-152
Purpose::Tibial stress fracture associated with knee osteoarthritis is an unusual and difficult clinical scenario. There is no clear existing treatment guideline for this uncommon clinical disease. The aim of this study is to review the impact of various treatment options for patients with advanced knee osteoarthritis associated with proximal tibial stress fracture.Methods::The study was performed using the databases of PubMed and Scopus. Methodological index for non-randomized studies score was used to evaluate the included studies’ bias. The concluded data included the treatment approach, reported outcome measure, and time to fracture union. The literature search was started in December 2021 and accomplished in January 2022. A narrative description of the different methods and comparison of their results were done.Results::Out of total assessed 69 studies, 9 studies were included in our review. The commonest treatment approach used was total knee arthroplasty by long tibial stem extension. The mean preoperative knee society score and knee functional score were 30.62 and 23.17, respectively. The mean postoperative knee society knee score was 86.87, while the functional score was 83.52. The average reported time to achieve fracture union was 4 months (a range of 2.07 - 5.50 months).Conclusion::The optimal clinical outcome for treating either acute or mobile tibial stress fracture in patients with advanced knee osteoarthritis can be achieved with long stem total knee arthroplasty. However, due to heterogeneity of data, comparison of different treatment options for chronic proximal tibial stress fracture mal-union/non-union coexisting with knee osteoarthritic and such inferences need to be judged cautiously.
2.Effect of audio distraction with thermomechanical stimulation on pain perception for inferior alveolar nerve block in children: a randomized clinical trial
Devendra NAGPAL ; Dharanshi Viral AMLANI ; Pooja RATHI ; Kavita HOTWANI ; Prabhat SINGH ; Gagandeep LAMBA
Journal of Dental Anesthesia and Pain Medicine 2023;23(6):327-335
Background:
Pain control is a crucial aspect of pediatric dentistry for patient management. Thermo-mechanical devices (Buzzy TM Pain Care Labs, USA) work on the concept of vibration and cooling and have shown promising results in pain control during local anesthesia in pediatric dentistry. On the other hand, audio distraction has also been used for pain management. The amount of pain endured is determined by the patient's perception and attentiveness. Thus, if audio function is added to the thermomechanical device it might increase its efficiency. Hence, the present study aimed to compare pain on injection using a thermo-mechanical device with and without audio during inferior alveolar nerve block (IANB) injection in children aged 5-10 years old.
Methods:
Twenty-eight children aged between 5 and 10 indicated for IANB were included in this randomized study. Children who were undergoing the dental procedure were divided into 2 groups, with 14 children in each group. The study group was the thermo-mechanical device with audio distraction; the control group was the thermo-mechanical device without audio distraction. IANB was administered. Subjective pain evaluation was performed using the Wong–Baker Faces Pain Rating Scale (WBFPR) and objective pain evaluation was done using the Faces, Leg, Activity, Consolability, Cry (FLACC) scale.
Results:
The outcome depicted a significant reduction in pain on injection for both objective and subjective evaluations in the thermo-mechanical device with an audio distraction group.
Conclusions
Less pain on injection was observed, when a thermo-mechanical device was used with audio distraction for IANB procedures.
3.Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
Arshdeep SINGH ; Vandana MIDHA ; Vikram NARANG ; Saurabh KEDIA ; Ramit MAHAJAN ; Pavan DHOBLE ; Bhavjeet Kaur KAHLON ; Ashvin Singh DHALIWAL ; Ashish TRIPATHI ; Shivam KALRA ; Narender Pal JAIN ; Namita BANSAL ; Rupa BANERJEE ; Devendra DESAI ; Usha DUTTA ; Vineet AHUJA ; Ajit SOOD
Intestinal Research 2023;21(4):452-459
Background/Aims:
Primary sclerosing cholangitis (PSC) represents the most common hepatobiliary extraintestinal manifestation of inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). Limited data exist on PSC in patients with IBD from India. We aimed to assess the prevalence and disease spectrum of PSC in Indian patients with IBD.
Methods:
Database of IBD patients at 5 tertiary care IBD centers in India were analyzed retrospectively. Data were extracted and the prevalence of PSC-IBD was calculated.
Results:
Forty-eight patients out of 12,216 patients with IBD (9,231 UC, 2,939 CD, and 46 IBD unclassified) were identified to have PSC, resulting in a prevalence of 0.39%. The UC to CD ratio was 7:1. Male sex and pancolitis (UC) or colonic CD were more commonly associated with PSC-IBD. The diagnosis of IBD preceded the diagnosis of PSC in most of the patients. Majority of the patients were symptomatic for liver disease at diagnosis. Eight patients (16.66%) developed cirrhosis, 5 patients (10.41%), all UC, developed malignancies (3 colorectal cancer [6.25%] and 2 cholangiocarcinoma [4.16%]), and 3 patients died (2 decompensated liver disease [4.16%] and 1 cholangiocarcinoma [2.08%]) on follow-up. None of the patients mandated surgical therapy for IBD.
Conclusions
Concomitant PSC in patients with IBD is uncommon in India and is associated with lower rates of development of malignancies.
4.Use of thiopurines in inflammatory bowel disease: an update
Arshdeep SINGH ; Ramit MAHAJAN ; Saurabh KEDIA ; Amit Kumar DUTTA ; Abhinav ANAND ; Charles N. BERNSTEIN ; Devendra DESAI ; C. Ganesh PAI ; Govind MAKHARIA ; Harsh Vardhan TEVETHIA ; Joyce WY MAK ; Kirandeep KAUR ; Kiran PEDDI ; Mukesh Kumar RANJAN ; Perttu ARKKILA ; Rakesh KOCHHAR ; Rupa BANERJEE ; Saroj Kant SINHA ; Siew Chien NG ; Stephen HANAUER ; Suhang VERMA ; Usha DUTTA ; Vandana MIDHA ; Varun MEHTA ; Vineet AHUJA ; Ajit SOOD
Intestinal Research 2022;20(1):11-30
Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease. As the disease prevalence is on a steady rise, management of IBD has come under the spotlight. 5-Aminosalicylates, corticosteroids, immunosuppressive agents and biologics are the backbone of treatment of IBD. With the advent of biologics and small molecules, the need for surgery and hospitalization has decreased. However, economic viability and acceptability is an important determinant of local prescription patterns. Nearly one-third of the patients in West receive biologics as the first/initial therapy. The scenario is different in developing countries where biologics are used only in a small proportion of patients with IBD. Increased risk of reactivation of tuberculosis and high cost of the therapy are limitations to their use. Thiopurines hence become critical for optimal management of patients with IBD in these regions. However, approximately one-third of patients are intolerant or develop adverse effects with their use. This has led to suboptimal use of thiopurines in clinical practice. This review article discusses the clinical aspects of thiopurine use in patients with IBD with the aim of optimizing their use to full therapeutic potential.
5.Buffered articaine infiltration for primary maxillary molar extractions: a randomized controlled study
Parag DHAKE ; Devendra NAGPAL ; Purva CHAUDHARI ; Gagandeep LAMBA ; Kavita HOTWANI ; Prabhat SINGH
Journal of Dental Anesthesia and Pain Medicine 2022;22(5):387-394
Background:
Dental pain management is an important aspect of patient management in pediatric dentistry. Articaine is considered the most successful anesthetic agent for infiltration anesthesia. Buffered articaine has been observed to have faster onset and longer duration of action with less pain on injection. The aim of this study was to evaluate and compare pain on injection, onset of action, and pain during extraction using buffered (using Sodium bicarbonate (NaHCO 3 )) and non-buffered 4% articaine (with 1:100000 adrenaline) infiltrations for primary maxillary molar extractions in 4–10-year-old children.
Methods:
Seventy children who required extraction of maxillary primary molars were enrolled in this triple-blind randomized study. Children undergoing extraction were randomly divided into two groups, with 35 in each group. The study group was the buffered articaine group; the control group was the non-buffered articaine group. Buccal and palatal infiltrations were administered with either buffered or non-buffered articaine. Subjective evaluation was done for pain on injection, pain during extraction using Wong–Baker Faces Pain Rating Scale (WBFPR) and onset of anesthesia in seconds. Pain on injection, pain during extraction were objectively evaluated using Sound Eye Motor (SEM) scale and onset of anesthesia was also evaluated objectively by pricking with sharp dental probe.
Results:
The outcome was, significantly less pain on injection and significantly faster onset of anesthesia with significantly less pain during extraction for both subjective and objective evaluations in the buffered articaine group. Subgroup analysis was also performed and it showed variable results, with only significant difference for WBFPR scores in age subgroup 4–7 years for palatal infiltration.
Conclusion
Less pain on injection, faster onset of anesthesia, and less pain during extraction were observed when buffered articaine was used for maxillary primary molar extraction.
6.Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
Ajit SOOD ; Kirandeep KAUR ; Ramit MAHAJAN ; Vandana MIDHA ; Arshdeep SINGH ; Sarit SHARMA ; Amarender Singh PURI ; Bhabhadev GOSWAMI ; Devendra DESAI ; C. Ganesh PAI ; Kiran PEDDI ; Mathew PHILIP ; Rakesh KOCHHAR ; Sandeep NIJHAWAN ; Shobna BHATIA ; N. Sridhara RAO
Intestinal Research 2021;19(2):206-216
Background/Aims:
The national registry for inflammatory bowel disease (IBD) was designed to study epidemiology and prescribing pattern of treatment of IBD in India.
Methods:
A multicenter, cross-sectional, prospective registry was established across four geographical zones of India. Adult patients with ulcerative colitis (UC) or Crohn’s disease (CD) were enrolled between January 2014 and December 2015. Information related to demographics; disease features; complications; and treatment history were collected and analyzed.
Results:
A total of 3,863 patients (mean age, 36.7 ± 13.6 years; 3,232 UC [83.7%] and 631 CD [16.3%]) were enrolled. The majority of patients with UC (n = 1,870, 57.9%) were from north, CD was more common in south (n = 348, 55.5%). The UC:CD ratio was 5.1:1. There was a male predominance (male:female = 1.6:1). The commonest presentation of UC was moderately severe (n = 1,939, 60%) and E2 disease (n = 1,895, 58.6%). Patients with CD most commonly presented with ileocolonic (n = 229, 36.3%) inflammatory (n = 504, 79.9%) disease. Extraintestinal manifestations were recorded among 13% and 20% of patients in UC and CD respectively. Less than 1% patients from both cohorts developed colon cancer (n = 26, 0.7%). The commonly used drugs were 5-aminosalicylates (99%) in both UC and CD followed by azathioprine (34.4%). Biologics were used in only 1.5% of patients; more commonly for UC in north and CD in south.
Conclusions
The national IBD registry brings out diversities in the 4 geographical zones of India. This will help in aiding research on IBD and improving quality of patient care.
7.Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
Ajit SOOD ; Kirandeep KAUR ; Ramit MAHAJAN ; Vandana MIDHA ; Arshdeep SINGH ; Sarit SHARMA ; Amarender Singh PURI ; Bhabhadev GOSWAMI ; Devendra DESAI ; C. Ganesh PAI ; Kiran PEDDI ; Mathew PHILIP ; Rakesh KOCHHAR ; Sandeep NIJHAWAN ; Shobna BHATIA ; N. Sridhara RAO
Intestinal Research 2021;19(2):206-216
Background/Aims:
The national registry for inflammatory bowel disease (IBD) was designed to study epidemiology and prescribing pattern of treatment of IBD in India.
Methods:
A multicenter, cross-sectional, prospective registry was established across four geographical zones of India. Adult patients with ulcerative colitis (UC) or Crohn’s disease (CD) were enrolled between January 2014 and December 2015. Information related to demographics; disease features; complications; and treatment history were collected and analyzed.
Results:
A total of 3,863 patients (mean age, 36.7 ± 13.6 years; 3,232 UC [83.7%] and 631 CD [16.3%]) were enrolled. The majority of patients with UC (n = 1,870, 57.9%) were from north, CD was more common in south (n = 348, 55.5%). The UC:CD ratio was 5.1:1. There was a male predominance (male:female = 1.6:1). The commonest presentation of UC was moderately severe (n = 1,939, 60%) and E2 disease (n = 1,895, 58.6%). Patients with CD most commonly presented with ileocolonic (n = 229, 36.3%) inflammatory (n = 504, 79.9%) disease. Extraintestinal manifestations were recorded among 13% and 20% of patients in UC and CD respectively. Less than 1% patients from both cohorts developed colon cancer (n = 26, 0.7%). The commonly used drugs were 5-aminosalicylates (99%) in both UC and CD followed by azathioprine (34.4%). Biologics were used in only 1.5% of patients; more commonly for UC in north and CD in south.
Conclusions
The national IBD registry brings out diversities in the 4 geographical zones of India. This will help in aiding research on IBD and improving quality of patient care.
8.Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
Ajit SOOD ; Vineet AHUJA ; Vandana MIDHA ; Saroj Kant SINHA ; C. Ganesh PAI ; Saurabh KEDIA ; Varun MEHTA ; Sawan BOPANNA ; Philip ABRAHAM ; Rupa BANERJEE ; Shobna BHATIA ; Karmabir CHAKRAVARTTY ; Sunil DADHICH ; Devendra DESAI ; Manisha DWIVEDI ; Bhabhadev GOSWAMI ; Kirandeep KAUR ; Rajeev KHOSLA ; Ajay KUMAR ; Ramit MAHAJAN ; S. P. MISRA ; Kiran PEDDI ; Shivaram Prasad SINGH ; Arshdeep SINGH
Intestinal Research 2020;18(4):355-378
Despite several recent advances in therapy in inflammatory bowel disease (IBD), 5-aminosalicylic acid (5-ASA) therapy has retained its place especially in ulcerative colitis. This consensus on 5-ASA is obtained through a modified Delphi process, and includes guiding statements and recommendations based on literature evidence (randomized trials, and observational studies), clinical practice, and expert opinion on use of 5-ASA in IBD by Indian gastroenterologists. The aim is to aid practitioners in selecting appropriate treatment strategies and facilitate optimal use of 5-ASA in patients with IBD.
9.Outcome of ACL Reconstruction for Chronic ACL Injury in Knees without the Posterior Horn of the Medial Meniscus: Comparison with ACL Reconstructed Knees with An Intact Medial Meniscus
Kevin SYAM ; Devendra K CHOUHAN ; Mandeep Singh DHILLON
The Journal of Korean Knee Society 2017;29(1):39-44
PURPOSE: Cadaveric studies have shown that deficiency of the posterior horn of the medial meniscus (PHMM) increases strain on the anterior cruciate ligament (ACL) graft. However, its influence on the clinical and radiological outcome after ACL reconstruction is less discussed and hence evaluated in this study. MATERIALS AND METHODS: This study included 77 cases of ACL reconstruction with a minimum 18-month follow-up. Of the 77 cases, 41 patients with intact menisci were compared clinically and radiologically with 36 patients with an injury to the PHMM that required various grades of meniscectomy. The knees were evaluated using subjective International Knee Documentation Committee (IKDC) score and Orthopadische Arbeitsgruppe Knie (OAK) score. RESULTS: Cases with intact menisci showed better stability (p=0.004) at an average of 44.51 months after surgery. No significant differences were noted in the overall OAK score, subjective IKDC score, and functional OAK score (p=0.082, p=0.526, and p=0.363, respectively). The incidence of radiological osteoarthrosis was significantly higher in the posterior horn deficient knees (p=0.022). CONCLUSIONS: The tendency toward relatively higher objective instability and increased incidence of osteoarthrosis in the group with absent posterior horn reinforces its importance as a secondary stabiliser of the knee.
Animals
;
Anterior Cruciate Ligament
;
Cadaver
;
Follow-Up Studies
;
Horns
;
Humans
;
Incidence
;
Knee
;
Menisci, Tibial
;
Osteoarthritis
;
Tears
;
Transplants
10.Retrieval of Distally Migrated Coils with Detachable Intracranial Stent during Coil Embolization of Cerebral Aneurysm.
Devendra Pal SINGH ; Soon Chan KWON ; Lijin HUANG ; Won Joo LEE
Journal of Cerebrovascular and Endovascular Neurosurgery 2016;18(1):48-54
Migration of coils during endovascular procedures is a rare, but well-known complication. We are reporting two cases of successfully retrieving migrated coil using detachable intracranial stent. In both of our cases there was distal migration of coil during the intracranial aneurysm coiling procedure. The Solitaire® AB stent (Covidien, Irvine, CA, USA) was used to retrieve those coils. The stent was passed distal to the migrated coil using standard technique. It was then partially deployed and gradually withdrawn along with the entangled coil. Coil retrieval using the fully retrievable intracranial stent is a very simple, safe and easily available alternative for retrieval of distally migrated coil.
Embolization, Therapeutic*
;
Endovascular Procedures
;
Intracranial Aneurysm*
;
Stents*

Result Analysis
Print
Save
E-mail